CeriBell, Inc. (CBLL) dividends
CBLL on Nasdaq, Health Care
Sign in to get an email when it declares a dividend.
CeriBell, Inc. dividend: key facts
Own CeriBell, Inc.? See exactly what it will pay you
Add your shares to a free DiviCompass portfolio to see your next CBLL dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.
Price history
End-of-day closes on Nasdaq in USD. Dots mark ex-dividend dates.
Dividend history
Declared dividends. Special dividends are marked and excluded from yield and forecasts.
Reported financials
Annual figures from filings, converted to units.
Next 12 months
No dividends expected from the data available.
Estimate confidence: None
Company news
- Ceribell reports Q3 EPS (55c), consensus (52c)4 Nov 2026 · TheFly
Reports Q3 revenue $29.34M, consensus $29.16M. âOur third quarter results reflect new highs in account additions and utilization within our existing account base, demonstrating the strength of our cor...
- Ceribell price target raised to $33 from $26 at Canaccord4 Nov 2026 · TheFly
Canaccord raised the firmâs price target on Ceribell (CBLL) to $33 from $26 and keeps a Buy rating on the shares. The firm updated its model following inline Q3 resultsâ¦
- Ceribell narrows FY26 revenue view to $115M-$117M from $114M-$117M4 Nov 2026 · TheFly
Consensus $114.48M. The company said, âCeribell (CBLL) is raising its revenue guidance for the full year 2026 to a range of $115 million to $117 million, representing growth of approximatelyâ¦
- Ceribell Reports Third Quarter 2026 Financial Results4 Nov 2026 · GlobeNewsWire
SUNNYVALE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (âCeribellâ), a medical technology company focused on transforming the diagnosis and management of patients with seri...
- Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution2 Nov 2026 · GlobeNewsWire
SUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (âCeribellâ or the âCompanyâ), a medical technology company focused on transforming the diagnosis and management of p...
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum29 Oct 2026 · GlobeNewsWire
SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (âCeribellâ), a medical technology company focused on transforming the diagnosis and management of patients with seri...
- Ceribell to Report Third Quarter 2026 Financial Results on November 3, 202621 Oct 2026 · GlobeNewsWire
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (âCeribellâ), a medical technology company focused on transforming the diagnosis and management of patients with seri...
- Ceribell receives FDA 510k clearance of quantitative EEG trending, analysis3 Oct 2026 · TheFly
CeriBell (CBLL) announced that the U.S. Food and Drug Administration, FDA, has cleared new software for the Ceribell System that âmakes it easier and fasterâ for clinicians to interpret longitudinalâ¦
Insufficient verified data for a financial-health score
Dividend data and price last updated 18 Nov 2026.